Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The global epinephrine market size was valued at USD 1.60 billion in 2021, and it is projected to grow from USD 1.75 billion in 2022 to USD 3.63 billion by 2029, exhibiting a CAGR of 11.0% during the forecast period.
The rising prevalence of medical conditions, such as anaphylaxis, cardiovascular diseases, respiratory diseases (asthma), and others, along with the increasing awareness about the treatment options for the management of these diseases, is creating various growth opportunities in the market.
This information is provided by Fortune Business Insights, in its report titled, “Epinephrine Market, 2022-2029.”
Key Industry Development:
November 2021: Marathon Asset Management procured kaleo, Inc. to fast track development, manufacturing, and commercialization of kaleo’s medical goods.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/epinephrine-market-104291
Key Takeaways:
- From January 2011 to June 2015, Medicaid paid for 2.7 million prescriptions, or roughly 600,000 per year.
- EpiPen Jr Auto-Injector, 0.15 mg, has been made available in the United States, according to Teva Pharmaceutical Industries Ltd. The majority of retail pharmacies carried the product.
- During the COVID-19 pandemic, fewer EpiPen (auto-injector) prescriptions were written in the United States. The total number of prescriptions filled for Mylan's generic EpiPen fell by 33.7% in 2020.
- In order to hasten the research, production, and marketing of kaleo's medical products, Marathon Asset Management purchased kaleo, Inc.
Discover the Leading Players Featured in the Report:
Teva Pharmaceutical Industries Ltd. (Israel), Viatris Inc. (U.S.), kaleo, Inc. (U.S.), Bausch Health Companies Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), USWM, LLC. (U.S.), BIOPROJET (France), ALK-Abelló A/S (Denmark)
Report Scope
| Report Coverage | Details |
| Forecast Period | 2022 to 2029 |
| Forecast Period 2022 to 2029 CAGR | 11.0% |
| 2029 Value Projection | USD 3.63 Billion |
| Base Year | 2021 |
| Market Size in 2022 | USD 1.75 Billion |
| Historical Data for | 2018 to 2020 |
| No. of Pages | 181 |
Browse Complete Report Details: https://www.fortunebusinessinsights.com/epinephrine-market-104291
Drivers and Restraints:
Rising Occurrence and Huge Patient Pool Undergoing Treatment to Fuel Demand for Epinephrine
Along with the growing incidence of anaphylaxis across the world, the demand for epinephrine is surging in the emerging and established nations. In order to cater to the increasing demand, major market players are emphasizing on the introduction of inventive products offering novel method of administration. These companies are presently emphasizing on emerging technologically progressive injectors in the market.
Segments:
Auto-injectors Segment to Witness Notable Growth during the Forecast Period
On the basis of product type, the market is segmented into auto-injectors, pre filled syringes and ampoules & vials.
The auto-injectors segment led the market by revenue share owing of the benefits of these auto-injectors over other products.
Surging Prevalence of Anaphylaxis Accountable for Dominance of Segment
On the basis of application, the market is segmented into anaphylaxis, cardiac arrest, respiratory disorders, and others.
The anaphylaxis segment dominated the market during 2021 due to increasing occurrence of anaphylaxis across the globe.
Retail & Online Pharmacy Segment to Lead Market
On the basis of distribution channel, the market is segmented into hospital pharmacy and retail & online pharmacy.
The retail & online pharmacy segment dominated the market with a substantial share owing to the surging number of retail & online pharmacies, easy accessibility of auto-injectors, and an effortless obtainability of the products at online platforms of the companies, thereby sustaining the growth of this segment during the forecast period.
Geographically, the market is segregated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
By Product Type
- Auto-injectors
- Pre-filled Syringes
- Ampoules & Vials
By Application
- Anaphylaxis
- Cardiac Arrest
- Respiratory Disorders
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail & Online Pharmacy
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Quick Buy - Epinephrine Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/104291
Report Coverage:
The report presents a holistic study of the market for epinephrine along with current trends and future anticipations to establish proximate investment gains. An in-depth analysis of any upcoming opportunities, threats, competitions or driving factors is also mentioned in the report. Step by step, thorough regional analysis is offered. The COVID-19 impacts have been added to the report to help investors and business owners understand the threats better. The top players in the market are identified, and their strategies to bolster the market growth are shared in the report.
Regional Insights:
North America to Lead Stoked by Increasing Innovative Product Launches
North America held the largest epinephrine market share, valued at USD 1.02 billion in 2021. The region led owing to sufficient reimbursement guidelines in the U.S. for auto-injectors and surging product presentation of technologically progressive products in the market.
In Europe, the market will be chiefly fueled by the rising occurrence of numerous circumstances such as anaphylaxis, cardiovascular ailments, and others. In addition, the adoption and implementation of technologically advanced products in the region will foster the epinephrine market growth.
Asia Pacific is projected to grow at a considerable rate owing to fluctuating supervisory rules for the implementation of auto-injectors. Moreover, companies are escalating their global existence in the region to satisfy the demand.
Competitive Landscape:
Acquisitions Initiated by Key Companies to Promote Market Growth
The leading players in the market constantly opt for efficient strategies to bolster their brand value as well as promote market growth. One such efficient strategy is acquiring competitive companies and further securing a profit for the companies.
FAQ’s
How big is the Epinephrine Market?
Epinephrine Market size was USD 1.75 Billion in 2022.
How fast is the Epinephrine Market growing?
The Epinephrine Market will exhibit a CAGR of 11.0 % during the forecast period, 2022-2029
Related Reports:
Injectable Drug Delivery Market Share, Size, Trends and Forecast 2023-2030
Drug Delivery Systems Market Size, Share| Global Forecast Report 2029
Blood Cell Separation Market Trends, Growth | Global Forecast Report 2030
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.: +1 424 253 0390
U.K.: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Attachment
